So reports Reuters. The new scrutiny is a sign of the government’s ramped-up pharmaceutical industry antitrust efforts.
Read the full article from Reuters here.
Estimated reading time: 0 minutes, 22 seconds
Brand Name Drug Makers Under Microscope
Brand name drug makers are facing more lawsuits and federal investigations for a practice they’ve been carrying on for years: tweaking formulations for brand name drugs slightly just as their patents are about to expire, making it difficult for pharmacists to automatically substitute generic drugs for the redesigned brand.
Latest from PLP News
- LightGabler moves to an all-inclusive, cloud-hosted solution: Having ProLaw in the cloud for remote accessibility
- Sponsored: CASE STUDY - ProLaw's scope for customization benefits Case Linden PC
- Sponsored: CASE STUDY - Howard Kennedy A future-proof solution that meets law firm needs today and tomorrow
- Sponsored: 3E Case Study - Foley Lardner
- Top reasons law firms are accelerating digital transformation
Most Read
-
-
Apr 07 2013
-
Written by PLP News
In a sensational case that has reportedly “grabbed the attention…
-
-
-
Mar 31 2013
-
Written by PLP News
A DLA Piper associate’s e-mail stating “that bill shall know…
-
-
-
Jan 26 2014
-
Written by PLP News
A 55-year-old attorney at White & Case, who recently filed…
-
-
-
Jun 15 2014
-
Written by Tami Kamin Meyer
More than 1.2 million applications, or “apps,” are available at…
-